Vincerx Pharma Stock (NASDAQ: VINC) stock price, news, charts, stock research, profile.
Open | $0.950 |
Close | $0.900 |
Volume / Avg. | 531.096K / 1.104M |
Day Range | 0.853 - 0.950 |
52 Wk Range | 0.610 - 9.372 |
Market Cap | $19.092M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 5.3% |
Days to Cover | 1.44 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Vincerx Pharma (NASDAQ: VINC) through any online brokerage.
Other companies in Vincerx Pharma’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Dominari Holdings (NASDAQ:DOMH), Addex Therapeutics (NASDAQ:ADXN) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Vincerx Pharma (NASDAQ: VINC) was reported by Cantor Fitzgerald on Tuesday, April 9, 2024. The analyst firm set a price target for 0.00 expecting VINC to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Vincerx Pharma (NASDAQ: VINC) is $0.8916 last updated Today at April 18, 2024 at 4:04 PM EDT.
There are no upcoming dividends for Vincerx Pharma.
Vincerx Pharma’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Vincerx Pharma.
Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.